Management of herpesvirus infections

International Journal of Antimicrobial Agents

Volumn 42, Issue 2, 2013, Pages 119-128

  Evans, Cariad M ^a   Kudesia, Goura ^a   McKendrick, Mike ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Antivirals; Herpesvirus; Management

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; ETOPOSIDE; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; LEFLUNOMIDE; PENCICLOVIR; RITUXIMAB; VALACICLOVIR; VALGANCICLOVIR;

ADAPTIVE IMMUNITY; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BLOOD TOXICITY; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG PENETRATION; ELECTROLYTE DISTURBANCE; ENZYME INHIBITION; EPSTEIN BARR VIRUS; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; HYPOCALCEMIA; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; KAPOSI SARCOMA; NEUTROPENIA; PREGNANCY; PRIORITY JOURNAL; REMISSION; REVIEW; RUBELLA; VARICELLA ZOSTER VIRUS; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 84880316806     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.04.023     Document Type: Short Survey

References (149)

1. S.R. Paludan, A.G. Bowie, K.A. Horan, and K.A. Fitzgerald Recognition of herpesviruses by the innate immune system Nat Rev Immunol 11 2011 143 154
2. D. Simpson, and K.A. Lyseng-Williamson Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes Drugs 66 2006 2397 2416 (Pubitemid 46084812)
3. J. Piret, and G. Boivin Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management Antimicrob Agents Chemother 55 2011 459 472
4. M.J. Levin, T.H. Bacon, and J.J. Leary Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients Clin Infect Dis 39 Suppl. 5 2004 S248 S257
5. H.J. Field Persistent herpes simplex virus infection and mechanisms of virus drug resistance Eur J Clin Microbiol Infect Dis 8 1989 671 680 (Pubitemid 19207155)
6. A. Markham, D. Faulds, and Ganciclovir An update of its therapeutic use in cytomegalovirus infection Drugs 48 1994 455 484
7. P. Reusser Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts Expert Opin Invest Drugs 10 2001 1745 1753 (Pubitemid 32827433)
8. H.Y. Sun, M.M. Wagener, and N. Singh Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review Am J Transplant 8 2008 2111 2118
9. D.H. Dockrell, and C.V. Paya Human herpesvirus-6 and -7 in transplantation Rev Med Virol 11 2001 23 36
10. R.S. Sellar, and K.S. Peggs Management of multidrug-resistant viruses in the immunocompromised host Br J Haematol 156 2012 559 572
11. W.G. Nichols, L. Corey, T. Gooley, W.L. Drew, R. Miner, and M. Huang Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes Blood 97 2001 867 874 (Pubitemid 32154267)
12. G.M. Scott, A. Weinberg, W.D. Rawlinson, and S. Chou Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates Antimicrob Agents Chemother 51 2007 89 94 (Pubitemid 46047692)
13. V.C. Emery, and P.D. Griffiths Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy Proc Natl Acad Sci USA 97 2000 8039 8044 (Pubitemid 30460769)
14. L. Gérard, and D. Salmon-Céron Pharmacology and clinical use of foscarnet Int J Antimicrob Agents 5 1995 209 217
15. B.D. Kuppermann, M. Flores-Aguilar, J.I. Quiceno, L.S. Rickman, and W.R. Freeman Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome Arch Ophthalmol 111 1993 1359 1366 (Pubitemid 23296781)
16. F.M. Mattes, E.G. Hainsworth, A.M. Geretti, G. Nebbia, G. Prentice, and M. Potter A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients J Infect Dis 189 2004 1355 1361 (Pubitemid 38543583)
17. D.H. Dockrell Human herpesvirus 6: molecular biology and clinical features J Med Microbiol 52 2003 5 18 (Pubitemid 36106363)
18. M. Yoshida, M. Yamada, T. Tsukazaki, S. Chatterjee, F.D. Lakeman, and S. Nii Comparison of antiviral compounds against human herpesvirus 6 and 7 Antiviral Res 40 1998 73 84 (Pubitemid 28535173)
19. P. Bonnafous, L. Naesens, S. Petrella, A. Gautheret-Dejean, D. Boutolleau, and W. Sougakoff Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet Antiviral Ther 12 2007 877 888 (Pubitemid 47492557)
20. A. Ducancelle, G. Champier, S. Alain, F. Petit, M.J. Le Pors, and M.C. Mazeron A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet Antiviral Ther 11 2006 537 540 (Pubitemid 44024862)
21. D.J. Winston, J.A. Young, V. Pullarkat, G.A. Papanicolaou, R. Vij, and E. Vance Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study Blood 111 2008 5403 5410
22. L.H. Wang, R.W. Peck, Y. Yin, J. Allanson, R. Wiggs, and M.B. Wire Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects Antimicrob Agents Chemother 47 2003 1334 1342 (Pubitemid 36368594)
23. F.M. Marty, P. Ljungman, G.A. Papanicolaou, D.J. Winston, R.F. Chemaly, and L. Strasfeld Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial Lancet Infect Dis 11 2011 284 292
24. F.M. Marty, and M. Boeckh Maribavir and human cytomegalovirus - what happened in the clinical trials and why might the drug have failed? Curr Opin Virol 1 2011 555 562
25. M.N. Prichard, and E.R. Kern The search for new therapies for human cytomegalovirus infections Virus Res 157 2011 212 221
26. Marty FM, Winston D, Rowley SD, Boeckh M, Vance E, Papanicolaou G, et al. CMX001 for prevention and control of CMV infection in CMV-seropositive allogeneic stem-cell transplant recipients: a phase 2 randomized, double-blind, placebo-controlled, dose-escalation trial of safety, tolerability and antiviral activity. Centre for International Bone Marrow Transplant Research; 2012.
27. R.K. Avery, B.J. Bolwell, B. Yen-Lieberman, N. Lurain, W.J. Waldman, and D.L. Longworth Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection Bone Marrow Transplant 34 2004 1071 1075 (Pubitemid 40028840)
28. B. Chacko, and G.T. John Leflunomide for cytomegalovirus: bench to bedside Transpl Infect Dis 14 2012 111 120
29. G.T. John, J. Manivannan, S. Chandy, S. Peter, D.H. Fleming, and S.J. Chandy A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients Transplant Proc 37 2005 4303 4305 (Pubitemid 43016014)
30. Department of Health. Immunisation against infectious disease; 2006.
31. D.R. Snydman, R.H. Rubin, and B.G. Werner New developments in cytomegalovirus prevention and management Am J Kidney Dis 21 1993 217 228 (Pubitemid 23087619)
32. G. Nigro, S.P. Adler, R. La Torre, and A.M. Best Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection N Engl J Med 353 2005 1350 1362 (Pubitemid 41362703)
33. H. Buxmann, O.M. Stackelberg, R.L. Schlosser, G. Enders, M. Gonser, and M. Meyer-Wittkopf Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis J Perinat Med 40 2012 439 446
34. G. Nigro, S.P. Adler, G. Parruti, M.M. Anceschi, E. Coclite, and I. Pezone Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy - a case-control study of the outcome in children J Infect Dis 205 2012 215 227
35. S. Visentin, R. Manara, L. Milanese, A. Da Roit, G. Forner, and E. Salviato Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age Clin Infect Dis 55 2012 497 503
36. S.P. Adler Screening for cytomegalovirus during pregnancy Infect Dis Obstet Gynecol 2011 2011 1 9
37. S.P. Adler, and G. Nigro Findings and conclusions from CMV hyperimmune globulin treatment trials J Clin Virol 46 Suppl. 4 2009 S54 S57
38. D. Pagliara, and B. Savoldo Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients Curr Opin Infect Dis 25 2012 431 437
39. S. Modi, L. Van, A. Gewirtzman, N. Mendoza, B. Bartlett, and A.M. Tremaine Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology Ther Clin Risk Manage 4 2008 409 417 (Pubitemid 351711999)
40. F.Y. Aoki Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: four approved indications and 13 off-label uses Can J Infect Dis 14 2003 17 27 (Pubitemid 36389088)
41. R.C. Reichman, G.J. Badger, G.J. Mertz, L. Corey, D.D. Richman, and J.D. Connor Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial JAMA 251 1984 2103 2107 (Pubitemid 14133504)
42. Y. Bryson, M. Dillon, M. Lovett, D. Bernstein, E. Garratty, and J. Sayre Treatment of first episode genital HSV with oral acyclovir: long term follow-up of recurrences. A preliminary report Scand J Infect Dis Suppl 47 1985 70 75 (Pubitemid 16211586)
43. K.H. Fife, R.A. Barbarash, T. Rudolph, B. Degregorio, and R. Roth Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group Sex Transm Dis 24 1997 481 486 (Pubitemid 27452562)
44. S.K. Tyring, D. Baker, and W. Snowden Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir J Infect Dis 186 Suppl 1 2002 S40 S46
45. C. Cernik, K. Gallina, and R.T. Brodell The treatment of herpes simplex infections: an evidence-based review Arch Intern Med 168 2008 1137 1144 (Pubitemid 351831395)
46. R. Patel, S. Alderson, A. Geretti, A. Nilsen, E. Foley, and S. Lautenschlager IUSTI/WHO Europe. European guideline for the management of genital herpes, 2010 Int J STD AIDS 22 2011 1 10
47. C. Gardella, and Z. Brown Prevention of neonatal herpes BJOG 118 2011 187 192
48. E. Anzivino, D. Fioriti, M. Mischitelli, A. Bellizzi, V. Barucca, and F. Chiarini Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention Virol J 6 2009 40
49. Royal College of Obstetricians and Gynaecologists Genital herpes in pregnancy, management (Green-top 30) 2007 Royal College of Obstetricians and Gynaecologists
50. K.M. Stone, R. Reiff-Eldridge, A.D. White, J.F. Cordero, Z. Brown, and E.R. Alexander Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999 Birth Defects Res A Clin Mol Teratol 70 2004 201 207 (Pubitemid 38581386)
51. D. Money, and M. Steben Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines: guidelines for the management of herpes simplex virus in pregnancy. Number 208, June 2008 Int J Gynaecol Obstet 104 2009 167 171
52. L.M. Hollier, and G.D. Wendel Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection Cochrane Database Syst Rev 2008 CD004946
53. S.G. Pinninti, R. Angara, K.N. Feja, D.W. Kimberlin, C.T. Leach, and D.A. Conrad Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series J Pediatr 161 2012 134 138
54. S.H. James, D.W. Kimberlin, and R.J. Whitley Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection Antiviral Res 83 2009 207 213
55. B.J. Freij Management of neonatal herpes simplex virus infections Indian J Pediatr 71 2004 921 926 (Pubitemid 39576223)
56. D.W. Kimberlin, C.Y. Lin, R.F. Jacobs, D.A. Powell, L. Corey, and W.C. Gruber Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections Pediatrics 108 2001 230 238
57. S.I. Wolfert, E.P. de Jong, A.C. Vossen, J. Zwaveling, A.B. Te Pas, and F.J. Walther Diagnostic and therapeutic management for suspected neonatal herpes simplex virus infection J Clin Virol 51 2011 8 11
58. D.W. Kimberlin Neonatal herpes simplex infection Clin Microbiol Rev 17 2004 1 13 (Pubitemid 38120927)
59. D.W. Kimberlin, C.Y. Lin, R.F. Jacobs, D.A. Powell, L.M. Frenkel, and W.C. Gruber Natural history of neonatal herpes simplex virus infections in the acyclovir era Pediatrics 108 2001 223 229
60. A.J. Nahmias, R.J. Whitley, A.N. Visintine, Y. Takei, and C.A. Alford Jr. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance J Infect Dis 145 1982 829 836 (Pubitemid 12088959)
61. N.W. Davies, L.J. Brown, J. Gonde, D. Irish, R.O. Robinson, and A.V. Swan Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections J Neurol Neurosurg Psychiatry 76 2005 82 87 (Pubitemid 40013495)
62. M. Ziyaeyan, A. Alborzi, A. Borhani Haghighi, M. Jamalidoust, M. Moeini, and B. Pourabbas Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis Braz J Infect Dis 15 2011 211 214
63. T. Solomon, B.D. Michael, P.E. Smith, F. Sanderson, N.W. Davies, and I.J. Hart Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association national guidelines J Infect 64 2012 347 373
64. P. Cinque, G.M. Cleator, T. Weber, P. Monteyne, C.J. Sindic, and A.M. van Loon The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis J Neurol Neurosurg Psychiatry 61 1996 339 345 (Pubitemid 26355772)
65. R.J. Whitley, and B. Roizman Herpes simplex virus infections Lancet 357 2001 1513 1518 (Pubitemid 32488876)
66. J.D. Meyers, J.C. Wade, C.D. Mitchell, R. Saral, P.S. Lietman, and D.T. Durack Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host Am J Med 73 1982 229 235 (Pubitemid 12067791)
67. K.J. Vigil, and R.F. Chemaly Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults Expert Opin Pharmacother 11 2010 1901 1913
68. P. Ljungman Prophylaxis against herpesvirus infections in transplant recipients Drugs 61 2001 187 196 (Pubitemid 32210194)
69. I.M. Hann, H.G. Prentice, H.A. Blacklock, M.G. Ross, D. Brigden, and A.E. Rosling Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial Br Med J (Clin Res Ed) 287 1983 384 388 (Pubitemid 13026258)
70. R.J. Whitley, D.W. Kimberlin, and B. Roizman Herpes simplex viruses Clin Infect Dis 26 1998 541 553 quiz 554-5
71. J. Styczynski, P. Reusser, H. Einsele, R. de la Camara, C. Cordonnier, and K.N. Ward Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia Bone Marrow Transplant 43 2009 757 770
72. L.M. Dunkle, A.M. Arvin, R.J. Whitley, H.A. Rotbart, H.M. Feder Jr., and S. Feldman A controlled trial of acyclovir for chickenpox in normal children N Engl J Med 325 1991 1539 1544
73. H.H. Balfour Jr. Acyclovir for childhood chickenpox. No reason not to treat BMJ 310 1995 109 110
74. M.W. McKendrick Acyclovir for childhood chickenpox. Cost is unjustified BMJ 310 1995 108 109
75. T.P. Klassen, L. Hartling, N. Wiebe, and E.M. Belseck Acyclovir for treating varicella in otherwise healthy children and adolescents Cochrane Database Syst Rev 2005 CD002980
76. M.R. Wallace, W.A. Bowler, N.B. Murray, S.K. Brodine, and E.C. Oldfield 3rd Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial Ann Intern Med 117 1992 358 363
77. H.H. Balfour Jr., C.K. Edelman, R.S. Anderson, N.V. Reed, R.M. Slivken, and L.H. Marmor Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance Pediatr Infect Dis J 20 2001 919 926 (Pubitemid 32952666)
78. D.G. Partridge, and M.W. McKendrick The treatment of varicella-zoster virus infection and its complications Expert Opin Pharmacother 10 2009 797 812
79. A.H. Mohsen, and M. McKendrick Varicella pneumonia in adults Eur Respir J 21 2003 886 891 (Pubitemid 36592302)
80. M. Alanezi Varicella pneumonia in adults: 13 years' experience with review of literature Ann Thorac Med 2 2007 163 165 (Pubitemid 350099066)
81. G. Enders Varicella-zoster infection in pregnancy Prog Med Virol 29 1984 166 196
82. J.H. Harger, J.M. Ernest, G.R. Thurnau, A. Moawad, V. Momirova, and M.B. Landon Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women J Infect Dis 185 2002 422 427 (Pubitemid 34142803)
83. G. Enders, E. Miller, J. Cradock-Watson, I. Bolley, and M. Ridehalgh Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases Lancet 343 1994 1548 1551 (Pubitemid 24180055)
84. A. Shrim, G. Koren, M.H. Yudin, and D. Farine Management of varicella infection (chickenpox) in pregnancy J Obstet Gynaecol Can 34 2012 287 292
85. M.J. Wood, R. Kay, R.H. Dworkin, S.J. Soong, and R.J. Whitley Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials Clin Infect Dis 22 1996 341 347 (Pubitemid 26056166)
86. H. Degreef, and Famciclovir Herpes Zoster Clinical Study Group Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients Int J Antimicrob Agents 4 1994 241 246 (Pubitemid 24334158)
87. S. Tyring, R.A. Barbarash, J.E. Nahlik, A. Cunningham, J. Marley, and M. Heng Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group Ann Intern Med 123 1995 89 96
88. J.C. Huff, B. Bean, H.H. Balfour Jr., O.L. Laskin, J.D. Connor, and L. Corey Therapy of herpes zoster with oral acyclovir Am J Med 85 1988 84 89
89. R.H. Dworkin, R.W. Johnson, J. Breuer, J.W. Gnann, M.J. Levin, and M. Backonja Recommendations for the management of herpes zoster Clin Infect Dis 44 Suppl. 1 2007 S1 S26
90. N. Chen, M. Yang, L. He, D. Zhang, M. Zhou, and C. Zhu Corticosteroids for preventing postherpetic neuralgia Cochrane Database Syst Rev 2010 CD005582
91. M.J. Wood, R.W. Johnson, M.W. McKendrick, J. Taylor, B.K. Mandal, and J. Crooks A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster N Engl J Med 330 1994 896 900 (Pubitemid 24094969)
92. S. Tyring, R. Belanger, W. Bezwoda, P. Ljungman, R. Boon, and R.L. Saltzman A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients Cancer Invest 19 2001 13 22 (Pubitemid 32233797)
93. D. Torre, and R. Tambini Acyclovir for treatment of infectious mononucleosis: a meta-analysis Scand J Infect Dis 31 1999 543 547 (Pubitemid 30068345)
94. E.K. Vouloumanou, P.I. Rafailidis, and M.E. Falagas Current diagnosis and management of infectious mononucleosis Curr Opin Hematol 19 2012 14 20
95. P.I. Rafailidis, M.N. Mavros, A. Kapaskelis, and M.E. Falagas Antiviral treatment for severe EBV infections in apparently immunocompetent patients J Clin Virol 49 2010 151 157
96. M. Gordinou de Gouberville, M. Janssen, A. Schrander-van der Meer, M. Eefting, N. Delfos, and C. van Nieuwkoop Overwhelming primary Epstein-Barr virus infection requiring corticosteroid treatment BMJ Case Rep 2011 2011 pii bcr0820114643
97. T. Martelius, M. Lappalainen, S.M. Aalto, A. Nihtinen, K. Hedman, and V.J. Anttila Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia Clin Microbiol Infect 16 2010 657 662
98. N.J. Balamuth, K.E. Nichols, M. Paessler, and D.T. Teachey Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis J Pediatr Hematol Oncol 29 2007 569 573 (Pubitemid 47356813)
99. M.C. Milone, D.E. Tsai, R.L. Hodinka, L.B. Silverman, A. Malbran, and M.A. Wasik Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy Blood 105 2005 994 996 (Pubitemid 40170866)
100. M.L. Gulley, and W. Tang Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder Clin Microbiol Rev 23 2010 350 366
101. A. Faye, T. Van Den Abeele, M. Peuchmaur, A. Mathieu-Boue, and E. Vilmer Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders Lancet 352 1998 1285 (Pubitemid 28470350)
102. S. Bhaduri-McIntosh, M.J. Rotenberg, B. Gardner, M. Robert, and G. Miller Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines Blood 111 2008 1334 1343 (Pubitemid 351213420)
103. C.M. Rooney, H.E. Heslop, and M.K. Brenner EBV specific CTL: a model for immune therapy Vox Sang 74 Suppl. 2 1998 497 498 (Pubitemid 28379826)
104. A. Worth, R. Conyers, J. Cohen, M. Jagani, R. Chiesa, and K. Rao Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation Br J Haematol 155 2011 377 385
105. M. Eddleston, S. Peacock, M. Juniper, and D.A. Warrell Severe cytomegalovirus infection in immunocompetent patients Clin Infect Dis 24 1997 52 56 (Pubitemid 27023672)
106. P.I. Rafailidis, E.G. Mourtzoukou, I.C. Varbobitis, and M.E. Falagas Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review Virol J 5 2008 47
107. A. Heininger, G. Jahn, C. Engel, T. Notheisen, K. Unertl, and K. Hamprecht Human cytomegalovirus infections in nonimmunosuppressed critically ill patients Crit Care Med 29 2001 541 547 (Pubitemid 32225295)
108. A. Heininger, H. Haeberle, I. Fischer, R. Beck, R. Riessen, and F. Rohde Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis Crit Care 15 2011 R77
109. M. Jain, S. Duggal, and T.D. Chugh Cytomegalovirus infection in non-immunosuppressed critically ill patients J Infect Dev Countries 5 2011 571 579
110. S. Kadambari, E.J. Williams, S. Luck, P.D. Griffiths, and M. Sharland Evidence based management guidelines for the detection and treatment of congenital CMV Early Hum Dev 87 2011 723 728
111. E.J. Plosa, J.C. Esbenshade, M.P. Fuller, and J.H. Weitkamp Cytomegalovirus infection Pediatr Rev 33 2012 156 163 quiz 163
112. S.P. Adler, G. Nigro, and L. Pereira Recent advances in the prevention and treatment of congenital cytomegalovirus infections Semin Perinatol 31 2007 10 18 (Pubitemid 46273658)
113. T. del Rosal, F. Baquero-Artigao, D. Blázquez, A. Noguera-Julian, D. Moreno-Pérez, and A. Reyes Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period J Clin Virol 55 2012 72 74
114. H. Einsele, P. Reusser, M. Bornhauser, P. Kalhs, G. Ehninger, and H. Hebart Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation Blood 107 2006 3002 3008
115. A. Asberg, A. Humar, A.G. Jardine, H. Rollag, M.D. Pescovitz, and H. Mouas Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients Am J Transplant 9 2009 1205 1213
116. D.H. Dockrell, S. Edwards, M. Fisher, I. Williams, and M. Nelson Evolving controversies and challenges in the management of opportunistic infections in HIV-seropositive individuals J Infect 63 2011 177 186
117. H. Agut Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections J Clin Virol 52 2011 164 171
118. H. Agut Acute human herpesvirus 6 (HHV-6) infections: when and how to treat? Pathol Biol (Paris) 59 2011 108 112 [in French]
119. E. Denes, L. Magy, K. Pradeau, S. Alain, P. Weinbreck, and S. Ranger-Rogez Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient Emerg Infect Dis 10 2004 729 731 (Pubitemid 38420312)
120. T. Olli-Lahdesmaki, L. Haataja, R. Parkkola, M. Waris, N. Bleyzac, and O. Ruuskanen High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child Pediatr Neurol 43 2010 53 56
121. Y.L. Lau, M. Peiris, G.C. Chan, A.C. Chan, D. Chiu, and S.Y. Ha Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion Bone Marrow Transplant 21 1998 1063 1066 (Pubitemid 28230673)
122. P. Ljungman Beta-herpesvirus challenges in the transplant recipient J Infect Dis 186 Suppl. 1 2002 S99 S109
123. D.M. Zerr, D. Gupta, M.L. Huang, R. Carter, and L. Corey Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients Clin Infect Dis 34 2002 309 317 (Pubitemid 34062230)
124. M. Ogata, T. Satou, R. Kawano, K. Goto, J. Ikewaki, and K. Kohno Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation Bone Marrow Transplant 41 2008 279 285 (Pubitemid 351260383)
125. P.J. de Pagter, R. Schuurman, H. Visscher, M. de Vos, M. Bierings, and A.M. van Loon Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome Biol Blood Marrow Transplant 14 2008 831 839 (Pubitemid 351773160)
126. S. Tokimasa, J. Hara, Y. Osugi, H. Ohta, Y. Matsuda, and H. Fujisaki Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation Bone Marrow Transplant 29 2002 595 598 (Pubitemid 34537720)
127. D. Rapaport, D. Engelhard, G. Tagger, R. Or, and N. Frenkel Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients Transpl Infect Dis 4 2002 10 16 (Pubitemid 34786820)
128. B.C. Betts, J.A. Young, C. Ustun, Q. Cao, and D.J. Weisdorf Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant 17 2011 1562 1568
129. D. Caiola, A. Karras, P. Flandre, D. Boutolleau, C. Scieux, and H. Agut Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation J Med Virol 84 2012 450 456
130. I. Lautenschlager, and R.R. Razonable Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review Transpl Int 25 2012 493 502
131. L.S. Wyatt, W.J. Rodriguez, N. Balachandran, and N. Frenkel Human herpesvirus 7: antigenic properties and prevalence in children and adults J Virol 65 1991 6260 6265
132. P.K. Chan, J.S. Peiris, K.Y. Yuen, R.H. Liang, Y.L. Lau, and F.E. Chen Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients J Med Virol 53 1997 295 305 (Pubitemid 28201842)
133. Y. Maeda, T. Teshima, M. Yamada, K. Shinagawa, S. Nakao, and Y. Ohno Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation Br J Haematol 105 1999 295 302 (Pubitemid 29197176)
134. P.K. Chan, K.W. Chik, K.F. To, C.K. Li, M.M. Shing, and K.C. Ng Case report: human herpesvirus 7 associated fatal encephalitis in a peripheral blood stem cell transplant recipient J Med Virol 66 2002 493 496 (Pubitemid 34203238)
135. J.C. Mendez, D.H. Dockrell, M.J. Espy, T.F. Smith, J.A. Wilson, and W.S. Harmsen Human beta-herpesvirus interactions in solid organ transplant recipients J Infect Dis 183 2001 179 184 (Pubitemid 32066016)
136. H.K. Osman, J.S. Peiris, C.E. Taylor, P. Warwicker, R.F. Jarrett, and C.R. Madeley 'Cytomegalovirus disease' in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? J Med Virol 48 1996 295 301
137. A. Mocroft, M. Youle, B. Gazzard, J. Morcinek, R. Halai, and A.N. Phillips Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group AIDS 10 1996 1101 1105 (Pubitemid 26283347)
138. S. Gantt, and C. Casper Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment Curr Opin Infect Dis 24 2011 295 301
139. M. Bower, C. Palmieri, and T. Dhillon AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy Curr Opin Infect Dis 19 2006 14 19 (Pubitemid 43032434)
140. H.K. Tam, Z.F. Zhang, L.P. Jacobson, J.B. Margolick, J.S. Chmiel, and C. Rinaldo Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma Int J Cancer 98 2002 916 922 (Pubitemid 34286691)
141. M. Bower, S. Collins, C. Cottrill, K. Cwynarski, S. Montoto, and M. Nelson British HIV Association guidelines for HIV-associated malignancies 2008 HIV Med 9 2008 336 388 (Pubitemid 352015641)
142. E. Boulanger, L. Gerard, J. Gabarre, J.M. Molina, C. Rapp, and J.F. Abino Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS J Clin Oncol 23 2005 4372 4380 (Pubitemid 46207011)
143. H.E. El-Osta, and R. Kurzrock Castleman's disease: from basic mechanisms to molecular therapeutics Oncologist 16 2011 497 511
144. A. Waterston, and M. Bower Fifty years of multicentric Castleman's disease Acta Oncol 43 2004 698 704 (Pubitemid 40066010)
145. T.S. Uldrick, M.N. Polizzotto, K. Aleman, D. O'Mahony, K.M. Wyvill, and V. Wang High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy Blood 117 2011 6977 6986
146. C. Casper New approaches to the treatment of human herpesvirus 8-associated disease Rev Med Virol 18 2008 321 329
147. E. Oksenhendler HIV-associated multicentric Castleman disease Curr Opin HIV AIDS 4 2009 16 21
148. M. Bower, T. Newsom-Davis, K. Naresh, S. Merchant, B. Lee, and B. Gazzard Clinical features and outcome in HIV-associated multicentric Castleman's disease J Clin Oncol 29 2011 2481 2486
149. J. Stebbing, C. Adams, A. Sanitt, S. Mletzko, M. Nelson, and B. Gazzard Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease Blood 118 2011 271 275